A pilot trial of S-1 plus irinotecan chemotherapy for esophageal adenocarcinoma.
Nakajima Y, Fujiwara N, Ryotokuji T, Ohta S, Okada T, Miyawaki Y, Hoshino A, Jirawat S, Tokairin Y, Kawada K, Nishikage T, Nagai K, Kawano T.
Nakajima Y, et al.
Hepatogastroenterology. 2012 Oct;59(119):2182-5. doi: 10.5754/hge11997.
Hepatogastroenterology. 2012.
PMID: 22366525